KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) EPS (Basic) (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of EPS (Basic) data on record, last reported at -$5.57 in Q4 2025.

  • For Q4 2025, EPS (Basic) fell 32.94% year-over-year to -$5.57; the TTM value through Dec 2025 reached -$2.91, down 1555.0%, while the annual FY2025 figure was -$2.91, 1555.0% down from the prior year.
  • EPS (Basic) reached -$5.57 in Q4 2025 per CRL's latest filing, down from $1.1 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $3.68 in Q4 2022 and bottomed at -$5.57 in Q4 2025.
  • Average EPS (Basic) over 5 years is $1.19, with a median of $1.76 recorded in 2024.
  • Peak YoY movement for EPS (Basic): skyrocketed 49.59% in 2022, then plummeted 214.48% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $2.73 in 2021, then skyrocketed by 34.8% to $3.68 in 2022, then fell by 0.54% to $3.66 in 2023, then tumbled by 214.48% to -$4.19 in 2024, then tumbled by 32.94% to -$5.57 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$5.57 in Q4 2025, $1.1 in Q3 2025, and $1.06 in Q2 2025.